Xie Yong, Zhu Jun, Zhou Xiao-jiang, Chen Jiang, Lu Nong-hua, Wang Chong-wen
Institute of Gastroenterology, First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Zhonghua Yi Xue Za Zhi. 2006 Oct 17;86(38):2683-9.
To investigate the expression of peroxisome proliferators-activated receptor-gamma (PPAR-gamma) and cyclooxygenase-2 (COX-2) in Helicobacter pylori (Hp)-associated gastric mucosal lesions and the relations among them.
Two-step immunohistochemical staining was used to detect the expression of PPAR-gamma and COX-2 proteins in the gastric biopsy specimens from 209 patients with lesions of gastric mucosa, including 75 cases of chronic superficial gastritis (CSG), 24 cases of chronic atrophic gastritis (CAG), and 90 cases of intestinal metaplasia (MI) and dysplasia (DYS), and from 20 subjects with normal gastric mucosa negative in Hp as controls. In addition, 36 CSG patients were followed up for 10 years to observe the changes of expression of PPAR-gamma and COX-2.
(1) The expression of COX-2 protein in the glandular cells of the CSG, CAG, and IM + DYS groups were 42.7%, 45.8%, and 61.1% respectively, all significantly higher than that of the control group (20%, P < 0.01 or 0.05). The expression of COX-2 protein in the inflammatory cells of the CSG, CAG, and IM + DYS groups were 32%, 29.2%, and 36.7% respectively, all significantly higher than that of the control group (0%, all P < 0.05). (2) In the CSG and IM + DYS groups the expression levels of COX-2 in both the inflammatory and glandular cells were both significantly higher in the Hp-positive patients than in the Hp-negative patients (P < 0.05 or 0.01). (3) The expression of PPAR-gamma protein in the glandular cells of the CSG, CAG, and IM + DYS groups were 18.7%, 29.2%, and 45.6% respectively, all significantly higher than that of the control group (0%, all P < 0.01); and the expression levels of PPAR-gamma protein in the inflammatory cells of the CSG, CAG, and IM + DYS groups were 22.5%, 20.8%, and 22.2% respectively, all significantly higher than that of the control group (0%, P < 0.05 or 0.01). (4) In the CSG and IM + DYS groups the expression levels of PPAR-gamma in the inflammatory cells of the Hp-positive patients were both significantly higher than those of the Hp-negative patients (both P < 0.01); and the. expression levels of PPAR-gamma in the glandular cells of the Hp-positive patients were both significantly higher than those of the Hp-negative patients (both P < 0.01). (5) The expression level of COX-2 in the inflammatory cells of the CSG patients with a persistent Hp infection after a period of ten years was 33.3%, significantly lower than that a decade before (38.9%, P < 0.05). However, the expression level of PPAR-gamma in the inflammatory cells of the patients with a persistent Hp infection after a period of ten years was 30.6%, not significantly different from that a decade before (33.3%, P > 0.05). (6) The expression levels of COX-2 and PPAR-gamma in the glandular cells of the CSG patients with a persistent Hp infection after a period of ten years were 55.6% and 30.6% respectively, both significantly higher than those a decade before (47.2% and 22.2%, both P < 0.01). (7) In all Hp-negative disease groups the expression level of COX-2 in the inflammatory cells was not significantly correlated with the expression level of PPAR-gamma in the inflammatory cells(r = 0.006 and 0.149, P > 0.05) In the Hp-negative disease groups, the expression level of COX-2 in the glandular cells was significantly positively correlated with the expression level of PPAR-gamma in the glandular cells in the IM + DYS group (r = 0.336, P < 0.05), however, not significantly correlated with the expression level of PPAR-gamma in the glandular cells in both CAG and CSG groups (r = 0.035 and 0.126, both P > 0.05). (8) In both the inflammatory cells and glandular cells the COX-2 expression was significantly positively correlated with the PAR-gamma expression in all disease groups with Hp positivity (r = 0.348 and 0.645, P < 0.05 or 0.01).
(1) Hp infection induces the overexpression of COX-2 and PPAR-gamma in the inflammatory and glandular cells within gastric mucosa, thus participating in the pathogenesis of gastric cancer (2) The expression of COX-2 induces by Hp is related to acute inflammation caused by Hp infection. In the glandular cells, significant increase of COX-2 and PPAR-gamma expression implies that along with time the expression of COX-2 and PPAR-gamma may change in advance of the morphological changes of the gastric mucosa.
探讨过氧化物酶体增殖物激活受体γ(PPAR-γ)和环氧化酶-2(COX-2)在幽门螺杆菌(Hp)相关胃黏膜病变中的表达及其相互关系。
采用两步免疫组织化学染色法检测209例胃黏膜病变患者胃活检标本中PPAR-γ和COX-2蛋白的表达,其中包括75例慢性浅表性胃炎(CSG)、24例慢性萎缩性胃炎(CAG)、90例肠化生(MI)和异型增生(DYS)患者,以及20例Hp阴性的正常胃黏膜患者作为对照。另外,对36例CSG患者进行10年随访,观察PPAR-γ和COX-2表达的变化。
(1)CSG、CAG及IM+DYS组腺细胞中COX-2蛋白表达分别为42.7%、45.8%和61.1%,均显著高于对照组(20%,P<0.01或0.05)。CSG、CAG及IM+DYS组炎症细胞中COX-2蛋白表达分别为32%、29.2%和36.7%,均显著高于对照组(0%,均P<0.05)。(2)CSG和IM+DYS组中,Hp阳性患者炎症细胞和腺细胞中COX-2的表达水平均显著高于Hp阴性患者(P<0.05或0.01)。(3)CSG、CAG及IM+DYS组腺细胞中PPAR-γ蛋白表达分别为18.7%、29.2%和45.6%,均显著高于对照组(0%,均P<0.01);CSG、CAG及IM+DYS组炎症细胞中PPAR-γ蛋白表达分别为22.5%、20.8%和22.2%,均显著高于对照组(0%,P<0.05或0.01)。(4)CSG和IM+DYS组中,Hp阳性患者炎症细胞中PPAR-γ的表达水平均显著高于Hp阴性患者(均P<0.01);Hp阳性患者腺细胞中PPAR-γ的表达水平均显著高于Hp阴性患者(均P<0.01)。(5)随访10年后持续Hp感染的CSG患者炎症细胞中COX-2表达水平为33.3%,显著低于10年前(38.9%,P<0.05)。然而,随访10年后持续Hp感染患者炎症细胞中PPAR-γ表达水平为30.6%,与10年前相比差异无统计学意义(33.3%,P>0.05)。(6)随访10年后持续Hp感染的CSG患者腺细胞中COX-2和PPAR-γ表达水平分别为55.6%和30.6%,均显著高于10年前(47.2%和22.2%,均P<0.01)。(7)在所有Hp阴性疾病组中,炎症细胞中COX-2表达水平与炎症细胞中PPAR-γ表达水平无显著相关性(r=0.006和0.149,P>0.05)。在Hp阴性疾病组中,IM+DYS组腺细胞中COX-2表达水平与腺细胞中PPAR-γ表达水平显著正相关(r=0.336,P<0.05),而CAG和CSG组腺细胞中COX-2表达水平与腺细胞中PPAR-γ表达水平无显著相关性(r=0.035和0.126,均P>0.05)。(8)在所有Hp阳性疾病组的炎症细胞和腺细胞中,COX-2表达与PAR-γ表达均显著正相关(r=0.348和0.645,P<0.05或0.01)。
(1)Hp感染诱导胃黏膜炎症细胞和腺细胞中COX-2和PPAR-γ的过表达,从而参与胃癌的发病机制。(2)Hp诱导的COX-2表达与Hp感染引起的急性炎症有关。在腺细胞中,COX-2和PPAR-γ表达的显著增加意味着随着时间的推移,COX-2和PPAR-γ的表达可能在胃黏膜形态学改变之前发生变化。